SLC7A11 and breast neoplasm: A similar effect was also demonstrated by Cobler et al. in 2018, who showed that xCT inhibition sensitized breast tumours to γ-radiation via glutathione reduction [322], suggesting a synergic role of xCT inhibition and ROS-generating therapies in killing cancer cells.